Chronic Lymphocytic Leukemia: Changes in frontline treatment

Jan 20, 2020 | Justin McClanahan, Moderator | @JustinMcClanahan

11_25_19_CLL_Ding

Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.

The term "chronic" in chronic lymphocytic leukemia comes from the fact that it typically progresses more slowly than other types of leukemia. The term "lymphocytic" in chronic lymphocytic leukemia comes from the cells affected by the disease — a group of white blood cells called lymphocytes, which help your body fight infection.

Wei Ding, M.B.B.S., Ph.D., discusses changes in CLL treatment that are altering the practice overall.

Have you or a loved one been diagnosed with CLL? Meet others who have also been diagnosed, undergone or are facing treatment and have some of the same experiences and concerns:

Interested in more newsfeed posts like this? Go to the Hematology blog.

Please sign in or register to post a reply.

Chronic Lymphocytic Leukemia: Changes in frontline treatment

Share this:

Have you or a loved one been diagnosed with CLL? Meet others who have also been diagnosed, undergone or are facing treatment and have some of the same experiences and concerns: